Marksans Pharma gets eight observations from USFDA for its Goa facility
The inspection of the facility took place between February 25 to March 6, 2019 resulting in a Form 483 with eight observations
Author
Lupin gets USFDA nod to market its cholesterol lowering drug
The company has received nod from the US health regulator to market its generic Atorvastatin Calcium tablets, used for lowering…
Beneficiaries give a thumbs up to Janaushadhi Kendras
Interacting with owners of Janaushadhi Kendras (JAKs) and beneficiaries, Prime Minister Narendra Modi enquired about the quality,…
March 7, 2019 to be celebrated as ‘Janaushadhi Diwas’ across India
Over 5,050 Janaushadhi stores functional across 652 districts in the country. Each block in the country to have a PMBJP Kendra by…
What gives you power? Your position or your person?
True leadership is about integrity, inspiration, insight and empathy. Just you being you is sufficient for others in the team to…
5th ‘Asia Pacific Pharmacovigilance Training Course’ being held in Ghaziabad
The course is tailored to regional needs and addresses challenges unique to pharmacovigilance
Shripad Naik lays foundation stone of National Institute of Unani Medicine at Ghaziabad
NIUM, Ghaziabad is being established as part of its commitment towards provision and promotion of quality education, research and…
AYUSH Minister to lay foundation stone for National Institute of Unani Medicine at Ghaziabad
Once established, the NIUM, Ghaziabad, with a 200-bedded hospital, would be one of the largest institutes of Unani Medicine in…
IDMA bags ‘India Pharma Swachhatta Champion Award’
IDMA Secretariat at Mumbai had conducted a cleanliness drive on 10th September, 2018 at B Y L Nair Charitable Hospital as part of…
Lupin launches chronic angina treatment drug in the US
The newly-launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences' Ranexa ER tablets